E-DRUG: WHO Publication: Safety Monitoring of Medicinal Products - Reporting system for the general public
---------------------------------------
Dear Colleagues,
A new WHO publication by the title: Safety Monitoring of Medicinal
Products - Reporting system for the general public
is now available on the WHO website:
http://www.who.int/medicines/areas/quality_safety/safety_efficacy/EMP_Co
nsumerReporting_web_v2.pdf [repair link if broken]
This document aims to provide practical guidelines on how to set up
national systems for consumers to report adverse reactions to medicines.
(Throughout this document, the phrase "consumer reporting" is used to
refer to reporting of adverse drug reactions (ADRs) by the general
public.)
The creation of a handbook for consumer reporting of ADRs was discussed
and requested at the thirty-first meeting of the National
Pharmacovigilance Centres held in Uppsala, Sweden from 20-23 October
2008, and the development of this publication has been incorporated into
the aims of the Seventh Framework Programme of the Research Directorate
of the European Commission and its project Monitoring Medicines
(http://www.monitoringmedicines.org/).
Dr Shanthi Pal
Pharmacovigilance Programme Manager
Quality Assurance and Safety: Medicines
Department of Essential Medicines and Health Products
World Health Organization
Geneva, Switzerland
Tel: + 41 22 791 1318
E-mail: pals@who.int
Website: http://www.who.int/medicines